$OOMA
OOMA INC

2015 Q3 Form 10-Q Financial Statement

#000156459015007936 Filed on September 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q1 2014 Q3
Revenue $21.14M $20.91M $16.70M
YoY Change 26.56% 38.48%
Cost Of Revenue $9.893M $11.06M $8.175M
YoY Change 21.02% 25.25%
Gross Profit $11.24M $9.850M $8.526M
YoY Change 31.87% 56.85%
Gross Profit Margin 53.19% 47.11% 51.05%
Selling, General & Admin $10.02M $9.630M $7.118M
YoY Change 40.76% 93.37%
% of Gross Profit 89.11% 97.77% 83.49%
Research & Development $4.284M $3.690M $2.930M
YoY Change 46.21% 80.88%
% of Gross Profit 38.1% 37.46% 34.37%
Depreciation & Amortization $450.0K $360.0K $300.0K
YoY Change 50.0% 63.64%
% of Gross Profit 4.0% 3.65% 3.52%
Operating Expenses $14.30M $13.32M $10.05M
YoY Change 42.35% 89.74%
Operating Profit -$3.060M -$3.470M -$1.522M
YoY Change 101.05% 368.92%
Interest Expense $600.0K -$590.0K $100.0K
YoY Change 500.0% 247.06%
% of Operating Profit
Other Income/Expense, Net -$10.00K -$40.00K $1.000K
YoY Change -1100.0% 300.0%
Pretax Income -$3.403M -$4.090M -$1.603M
YoY Change 112.29% 344.57%
Income Tax $0.00 $0.00 -$502.0K
% Of Pretax Income
Net Earnings -$3.403M -$4.090M -$1.101M
YoY Change 209.08% 344.57%
Net Earnings / Revenue -16.1% -19.56% -6.59%
Basic Earnings Per Share
Diluted Earnings Per Share -$803.8K -$243.0K -$65.36K
COMMON SHARES
Basic Shares Outstanding 16.73M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q1 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $59.17M $9.130M
YoY Change
Cash & Equivalents $59.17M $9.133M $4.547M
Short-Term Investments
Other Short-Term Assets $2.810M $3.200M
YoY Change
Inventory $7.221M $8.081M
Prepaid Expenses
Receivables $4.923M $4.394M
Other Receivables $0.00 $0.00
Total Short-Term Assets $74.13M $24.80M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $3.159M $2.893M
YoY Change
Goodwill $1.117M $1.117M
YoY Change
Intangibles $1.081M $1.278M
YoY Change
Long-Term Investments $700.0K
YoY Change
Other Assets $695.0K $1.188M
YoY Change
Total Long-Term Assets $6.052M $6.476M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $74.13M $24.80M
Total Long-Term Assets $6.052M $6.476M
Total Assets $80.18M $31.28M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.320M $3.967M
YoY Change
Accrued Expenses $11.49M $10.31M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $668.0K $1.562M
YoY Change
Long-Term Debt Due $670.0K $1.560M
YoY Change
Total Short-Term Liabilities $33.46M $30.66M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $292.0K $10.40M
YoY Change
Other Long-Term Liabilities $252.0K $980.0K
YoY Change
Total Long-Term Liabilities $544.0K $11.38M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $33.46M $30.66M
Total Long-Term Liabilities $544.0K $11.38M
Total Liabilities $34.00M $42.79M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$58.09M -$50.76M
YoY Change
Common Stock $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $46.18M -$45.15M
YoY Change
Total Liabilities & Shareholders Equity $80.18M $31.28M
YoY Change

Cashflow Statement

Concept 2015 Q3 2015 Q1 2014 Q3
OPERATING ACTIVITIES
Net Income -$3.403M -$4.090M -$1.101M
YoY Change 209.08% 344.57%
Depreciation, Depletion And Amortization $450.0K $360.0K $300.0K
YoY Change 50.0% 63.64%
Cash From Operating Activities -$2.020M -$680.0K -$10.00K
YoY Change 20100.0% -127.64%
INVESTING ACTIVITIES
Capital Expenditures -$460.0K -$230.0K -$220.0K
YoY Change 109.09% 130.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$670.0K
YoY Change -100.0%
Cash From Investing Activities -$460.0K -$230.0K -$890.0K
YoY Change -48.31% 130.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 48.02M 4.400M -340.0K
YoY Change -14223.53% -1860.0%
NET CHANGE
Cash From Operating Activities -2.020M -680.0K -10.00K
Cash From Investing Activities -460.0K -230.0K -890.0K
Cash From Financing Activities 48.02M 4.400M -340.0K
Net Change In Cash 45.54M 3.490M -1.240M
YoY Change -3772.58% 65.4%
FREE CASH FLOW
Cash From Operating Activities -$2.020M -$680.0K -$10.00K
Capital Expenditures -$460.0K -$230.0K -$220.0K
Free Cash Flow -$1.560M -$450.0K $210.0K
YoY Change -842.86% -117.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
OOMA
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
14348000
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13976000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
33457000
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2015-07-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4923000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4394000
CY2015Q3 us-gaap Inventory Net
InventoryNet
7221000
CY2015Q1 us-gaap Inventory Net
InventoryNet
8081000
CY2015Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
1690000
CY2015Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
2248000
CY2015Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
668000
CY2015Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
1562000
CY2015Q1 ooma Convertible Preferred Stock Warrant Liability Current
ConvertiblePreferredStockWarrantLiabilityCurrent
474000
CY2015Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
292000
CY2015Q3 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
6310000
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16684686
CY2015Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10398000
CY2015Q1 ooma Convertible Preferred Stock Warrant Liability Noncurrent
ConvertiblePreferredStockWarrantLiabilityNoncurrent
743000
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16684686
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3770000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
7790000
CY2015Q3 us-gaap Subscription Revenue
SubscriptionRevenue
17449000
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9893000
CY2014Q3 us-gaap Subscription Revenue
SubscriptionRevenue
12702000
us-gaap Subscription Revenue
SubscriptionRevenue
33025000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6813000
us-gaap Subscription Revenue
SubscriptionRevenue
23588000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4284000
CY2015Q3 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
3687000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3206000
CY2014Q3 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
3999000
us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
7963000
us-gaap Revenues
Revenues
40988000
us-gaap Revenues
Revenues
33000000
CY2014Q3 us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
4405000
us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
11934000
us-gaap Cost Of Goods Sold Subscription
CostOfGoodsSoldSubscription
8222000
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3583000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
8545000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1188000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
695000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Central Index Key
EntityCentralIndexKey
0001327688
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Entity Registrant Name
EntityRegistrantName
Ooma Inc
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2015Q3 us-gaap Goodwill
Goodwill
1117000
CY2015Q1 us-gaap Goodwill
Goodwill
1117000
CY2015Q3 us-gaap Assets
Assets
80181000
CY2015Q1 us-gaap Assets
Assets
31277000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7320000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3967000
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11493000
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1122000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10313000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
945000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
74129000
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16732591
CY2015Q1 us-gaap Assets Current
AssetsCurrent
24801000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3159000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59173000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9133000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2893000
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1081000
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1278000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1522000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
10048000
us-gaap Operating Expenses
OperatingExpenses
27256000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2218000
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
9412000
CY2015Q3 us-gaap Revenues
Revenues
21136000
CY2014Q3 us-gaap Revenues
Revenues
16701000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
14303000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3060000
CY2015Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-607000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
442000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
215000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7338000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-502000
us-gaap Net Income Loss
NetIncomeLoss
-7338000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
93000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
529000
us-gaap Net Income Loss
NetIncomeLoss
-602000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.14
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3422521
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2347728
us-gaap Depreciation And Amortization
DepreciationAndAmortization
670000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
412000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-502000
us-gaap Paid In Kind Interest
PaidInKindInterest
64000
us-gaap Paid In Kind Interest
PaidInKindInterest
28000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
332000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
124000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2217000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-860000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2734000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9560000
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2515065
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2930000
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000
CY2014Q3 us-gaap Gross Profit
GrossProfit
8526000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2515065
us-gaap Gross Profit
GrossProfit
21264000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5830000
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8175000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19724000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16767000
us-gaap Operating Income Loss
OperatingIncomeLoss
-776000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1288000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5231000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-3403000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12708000
us-gaap Gross Profit
GrossProfit
16233000
us-gaap Operating Expenses
OperatingExpenses
17009000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1603000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3403000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8381000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6167000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5992000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-502000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-1101000
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2185018
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
738000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
-45145000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31277000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
30664000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
252000
CY2015Q3 us-gaap Liabilities
Liabilities
34001000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50756000
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3340000
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4233193
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2273007
us-gaap Share Based Compensation
ShareBasedCompensation
1289000
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
us-gaap Share Based Compensation
ShareBasedCompensation
95000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
197000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
96000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58094000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
46180000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80181000
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q1 us-gaap Liabilities
Liabilities
42785000
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104272000
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5611000
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
980000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1289000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1104000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-372000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2724000
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-51000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-892000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-104000
CY2015Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-274000
CY2014Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
31000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000
CY2015Q3 us-gaap Gross Profit
GrossProfit
11243000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
51556000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
50040000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6364000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
us-gaap Interest Paid
InterestPaid
439000
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
451000
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
338000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
69000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
277000
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
9133000
CY2015Q3 us-gaap Interest Expense
InterestExpense
600000
CY2015Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
20000
CY2009Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
34397
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.70
CY2014Q3 us-gaap Interest Expense
InterestExpense
100000
CY2014Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
13000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1893239
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.85
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2410000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2022000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28000
us-gaap Interest Expense
InterestExpense
100000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-558000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
683000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
178000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-371000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3293000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2568000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-62000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
47000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-650000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-89000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
866000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
462000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
672000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-866000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1134000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
58848000
us-gaap Repayments Of Debt
RepaymentsOfDebt
11294000
us-gaap Repayments Of Debt
RepaymentsOfDebt
733000
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
475000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
61000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
139000
ooma Payments For Preferred Warrant Liability
PaymentsForPreferredWarrantLiability
584000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-594000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1817000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4547000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
us-gaap Interest Paid
InterestPaid
109000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
38629000
ooma Offering Costs Incurred But Not Yet Paid
OfferingCostsIncurredButNotYetPaid
1644000
ooma Adjustments To Additional Paid In Capital Derecognition Of Warrant Liability To Additional Paid In Capital
AdjustmentsToAdditionalPaidInCapitalDerecognitionOfWarrantLiabilityToAdditionalPaidInCapital
1075000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of the Company&#8217;s condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the <font style="Background-color:#FFFFFF;color:#;">condensed consolidated financial statements and the reported amounts of income and expenses during the reporting period. These estimates are based on information available as of the date of the condensed consolidated financial statements, and assumptions are inherently subjective in nature; therefore, actual results could differ from management&#8217;s estimates.</font> </p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Risk<font style="font-weight:normal;">&#8212;</font><font style="Background-color:#FFFFFF;color:#;font-weight:normal;"> The concentration of accounts receivable, net of allowance of returns of $0 and $0.1 million as of July 31, 2015 and January 31, 2015, respectively are as follows:</font><font style="font-weight:normal;"> </font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66%; border-bottom:solid 0.75pt transparent;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31%; border-bottom:solid 0.75pt #000000;0pt #000000;0pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66%;0pt #000000; border-bottom:solid 0.75pt transparent;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;0pt #000000; border-bottom:solid 0.75pt transparent;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;0pt #000000;0pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">July 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2015</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;0pt #000000; border-bottom:solid 0.75pt transparent;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;0pt #000000;0pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2015</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;0pt #000000; border-bottom:solid 0.75pt transparent;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66%;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer A</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66%;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer B</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66%;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer C</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;0pt #000000;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66%;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer D</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14%;0pt #000000;0pt #000000;0pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%;0pt #000000;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;0pt #000000;0pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* represents less than 10% during the period</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.57%;color:#;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">There were no customers that individually exceeded 10% of our revenue during the three and six months ended July&#160;31, 2015 and 2014.</font></p></div>
CY2010Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.70
CY2015Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.70
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2003-11-19
CY2015Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
6542
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2612
CY2015Q3 ooma Class Of Warrants Or Rights Termination
ClassOfWarrantsOrRightsTermination
556
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2015Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
CY2010Q4 ooma Convertible Preferred Stock Warrant Liability Settled
ConvertiblePreferredStockWarrantLiabilitySettled
600000
CY2010Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
13.00
CY2010Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
70287
CY2015Q3 ooma Warrant Exercised
WarrantExercised
21529
CY2015Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
13.00
CY2015Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
13752
CY2015Q3 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
66026
CY2015Q3 ooma Common Warrants Were Cash Exercised
CommonWarrantsWereCashExercised
6542
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2015Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
59173000
CY2015Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
798000
CY2015Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2912000
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5972000
CY2015Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5719000
CY2015Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1249000
CY2015Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2362000
CY2015Q3 us-gaap Deferred Revenue
DeferredRevenue
14012000
CY2015Q1 us-gaap Deferred Revenue
DeferredRevenue
14386000
CY2015Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
36000
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
38000
CY2015Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
4946000
CY2015Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4762000
CY2015Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
797000
CY2015Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1027000
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2502000
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
76630
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.04
CY2015Q1 ooma Class Of Warrant Or Right Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRightDateFromWhichWarrantsOrRightsExercisable
2025-01
us-gaap Interest Expense
InterestExpense
900000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
64000
CY2015Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
332000
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
600000
CY2009Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
21299
CY2015Q3 ooma Gain Loss On Termination Of Warrants
GainLossOnTerminationOfWarrants
100000
CY2015Q3 ooma Class Of Warrant Or Right Number Of Warrants Terminated
ClassOfWarrantOrRightNumberOfWarrantsTerminated
10099
CY2015Q3 ooma Expenses From Exercise Of Warrants
ExpensesFromExerciseOfWarrants
400000
CY2014Q3 ooma Stock Issued During Period Shares Stock Options Early Exercised
StockIssuedDuringPeriodSharesStockOptionsEarlyExercised
26393
ooma Stock Issued During Period Shares Stock Options Early Exercised
StockIssuedDuringPeriodSharesStockOptionsEarlyExercised
63893
CY2015Q3 ooma Stock Issued During Period Shares Stock Options Early Exercised
StockIssuedDuringPeriodSharesStockOptionsEarlyExercised
0
ooma Stock Issued During Period Shares Stock Options Early Exercised
StockIssuedDuringPeriodSharesStockOptionsEarlyExercised
0
CY2015Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
300000
CY2015Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
300000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
1000000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2919184
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10060755
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2919184
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10060755
CY2015Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2014Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
37000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.70
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.00
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.005
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.005
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.003
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.003
ooma Operating Lease Expiration Date
OperatingLeaseExpirationDate
2018-02
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
357000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
653000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
1010000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
50000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
960000
CY2015Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
668000
CY2015Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
292000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
775000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1589000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1202000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
27000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3593000
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
400000
CY2015Q3 us-gaap Purchase Obligation
PurchaseObligation
1900000
CY2015Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
355448
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
48758
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
14911
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
596737
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1989485
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.17
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.38
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.38
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.44
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.63
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.19
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M4D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y2M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y2M5D
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10109000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16899000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
7193000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
15470000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
95000
CY2015Q3 us-gaap Shares Outstanding
SharesOutstanding
87199
CY2014Q3 us-gaap Shares Outstanding
SharesOutstanding
13064

Files In Submission

Name View Source Status
0001564590-15-007936-index-headers.html Edgar Link pending
0001564590-15-007936-index.html Edgar Link pending
0001564590-15-007936.txt Edgar Link pending
0001564590-15-007936-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201509112023086691692.jpg Edgar Link pending
ooma-10q_20150731.htm Edgar Link pending
ooma-20150731.xml Edgar Link completed
ooma-20150731.xsd Edgar Link pending
ooma-20150731_cal.xml Edgar Link unprocessable
ooma-20150731_def.xml Edgar Link unprocessable
ooma-20150731_lab.xml Edgar Link unprocessable
ooma-20150731_pre.xml Edgar Link unprocessable
ooma-ex311_112.htm Edgar Link pending
ooma-ex312_113.htm Edgar Link pending
ooma-ex31_393.htm Edgar Link pending
ooma-ex321_114.htm Edgar Link pending
ooma-ex322_115.htm Edgar Link pending
ooma-ex32_394.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending